Upregulation of MYC Targets, Oxidative Phosphorylation, Adipogenesis, and DNA repair pathways also represents the molecular functions affected in pediatric OSA, providing potential drug target candidates capable of attenuating developmental impacts, and improving treatment efficacy. Here, MYC is linked to obstructive sleep apnea syndrome.